Patents by Inventor Naohiro Hanyu

Naohiro Hanyu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030124635
    Abstract: Streptococcus mutans in saliva or dental plaque collected from the oral cavity can be measured by the method of the present invention conveniently with high sensitivity without the performance of any complex procedure, such as culturing. The reactivity of the antibody of the present invention against Streptococcus mutans is 1000-fold or more greater than its reactivity against each of Streptococcus gordonii, Streptococcus salivarius, Streptococcus oralis, Streptococcus mitis, and Streptococcus sanguis.
    Type: Application
    Filed: December 17, 2002
    Publication date: July 3, 2003
    Applicant: Tokuyama Dental Corporation
    Inventors: Fumio Ukaji, Kouichirou Hirata, Naohiro Hanyu, Kazuo Fukushima
  • Publication number: 20030092086
    Abstract: The present invention provides an immunological method for the assay of Streptococcus sobrinus participating in dental caries, an antibody for use in the method, and a diagnostic kit. As the antibody, there is used an antibody whose binding ability for Streptococcus sobrinus is not less than 100 times that for Streptococcus mutans.
    Type: Application
    Filed: December 26, 2001
    Publication date: May 15, 2003
    Inventors: Kouichirou Hirata, Fumio Ukaji, Koji Matsushige, Naohiro Hanyu, Kazuo Fukushima
  • Patent number: 6033862
    Abstract: There are provided: an immunological reagent for diagnosis of or the evaluation of the effect of a medicine for dialysis-related amyloidosis, which includes an antibody which reacts specifically with a carboxymethylated .alpha.-amino acid, a carboxymethylated protein, or a carboxymethylated peptide; or, an immunological reagent for diagnosis of or the evaluation of the effect of a medicine for diabetes mellitus and diabetes mellitus complications, which includes an antibody which reacts specifically with an N.sup..alpha. -carboxymethylated .alpha.-amino acid, an N.sup..alpha. -carboxymethylated protein, or an N.sup..alpha. -carboxymethylated peptide. Methods using the immunological reagents are provided: for determination of carboxymethylated hemoglobin as a marker for dialysis-related amyloidosis; or, for determination of N.sup..alpha. -carboxymethylated hemoglobin as a marker for diabetes mellitus or diabetes mellitus complications.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: March 7, 2000
    Assignee: Tokuyama Corporation
    Inventors: Noriko Matsuda, Hisahiko Iwamoto, Naohiro Hanyu